Repligen Corp

RGENNASDAQ

Healthcare · Biological Products, (no Diagnostic Substances)

Market cap

$5.80B

Employees

2,000

Exchange

NASDAQ

Headquarters

Waltham, Massachusetts, United States

About Repligen Corp

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Industry

Biological Products, (no Diagnostic Substances)

Sector

Healthcare

Country

US

Website

www.repligen.com